US Listing
Clean Tech
Asian Pacific
Europe Listing
Bio-Life Sciences
Real Estate Fund
Australia Listing
Canada Listing
Israel Listing

Bio-Life Sciences



< 123 A B C D E F G H I J-K L M N O P Q-R S T-U V W-Z >



NBGI Ventures
Offices: London, England
NBGI Ventures is a leading venture capital fund investing in outstanding medical technology companies. Their mission is to help grow admirable, innovative and successful companies that will create a brighter future for their customers, patients and their society. With a dedicated focus specifically on the med-tech sector they aim to bring specialized expertise and value to their portfolio companies.
Offices: Oslo, Norway
NeoMed Management is an international investment firm, exclusively focusing on the healthcare and life science industry. Founded in 1996, NeoMed has established four funds, with total committed capital exceeding $200 million. NeoMed invests in young companies with outstanding growth prospects. Portfolio companies typically develop innovative products addressing inadequately served medical needs.
New Leaf Venture Partners
Offices: Menlo Park, California & New York, New York
New Leaf Venture Partners is a leader in healthcare technology venture investing. Their investment professionals bring a unique blend of technological, clinical, and operational experience to their investments. They work closely with their entrepreneurs to help build successful portfolio companies. They focus primarily on later stage biopharmaceutical products, early stage medical devices, and laboratory infrastructure technologies.
NewSpring Healthcare
Offices: Radnor, Pennsylvania & Short Hills, New Jersey
NewSpring Healthcare provides equity capital to healthcare companies within the life science, healthcare services and medical devices sectors. The Fund focuses its investments in growing sectors of the healthcare and pharmaceutical industries. NewSpring Healthcare emphasizes firms in the Mid-Atlantic region and Northeast corridor —a region rich in emerging biopharmaceutical, medical device, and healthcare service companies.


Nexus Medical Partners (NMP)
Offices: Boston, Massachusetts
Nexus Medical Partners is a private equity firm specializing in making private equity investments in and providing strategic assistance to medical technology and selected life science companies. Each of the Nexus principals averages twenty years in the business. In addition to being experienced equity investors, the backgrounds of the principals include successful careers in medical device and pharmaceutical line management.
Nomura Phase4 Ventures
Offices: Stockholm, Sweden
Phase4 Ventures is a global life science investor whose mission is to provide a premium rate of return for investors by creating, identifying and investing in development stage healthcare companies through its dedicated fund. Phase4 Ventures invests in biopharma, specialty pharmaceutical and medical device companies in the US and Europe. The Nomura team has expertise in structuring investments appropriate for the stage of the company.
Norwich Ventures (NV)
Offices: Wyomissing, Pennsylvania & Waltham, Massachusetts
Norwich Ventures is a venture capital firm committed to helping entrepreneurs, healthcare professionals and inventors build innovative medical device companies. They invest early in a company's life, often when it is just an idea. They are healthcare entrepreneurs ourselves and work as a team to bring their experience, industry expertise and network to every company we support. Norwich believes top-caliber support and guidance, not capital, is of greatest value to emerging companies.
Offices: Durham, NC
NovaQuest, Quintiles’ managed partnership group, creates long-term peer-to-peer relationships by leveraging a unique combination of global resources and management capabilities, scientific and commercial expertise, and corporate finance expertise and investment capital for pharmaceutical product development and commercialization.
Novartis Venture Fund
Offices: Basel, Switzerland & San Diego, California
The Novartis Venture Fund is based on the conviction that economic growth and the creation of new jobs can be achieved in the long run only if new entrepreneurial initiatives develop and promising ideas become business reality. With a venture capital of CHF 150 million and USD 100 million, the Fund supports new business projects that show exemplary entrepreneurial and innovative spirit in future-oriented areas, especially in the field of Health Sciences